简体中文
Two senior public relations experts advising the Food and Drug Administration have been ousted from their positions. /FDA
Two senior public relations experts advising the Food and Drug Administration have been ousted from their positions after President Trump and the head of the F.D.A. allegedly exaggerated the proven benefits of a blood plasma treatment for COVID-19.
On Friday, the F.D.A. commissioner, Dr. Stephen M. Hahn, removed Emily Miller as the agency's chief spokeswoman.
The White House had installed her in the post just 11 days earlier. Ms. Miller had previously worked in communications for the re-election campaign of Senator Ted Cruz and as a journalist for the conservative cable network One America News. Ms. Miller could not be reached for comment.
The New York Times correspondents Sheila Kaplan and Katie Thomas report that Ms. Miller's termination comes one day after the F.D.A.'s parent agency, the Department of Health and Human Services, terminated the contract of another public relations consultant, Wayne L. Pines, who had advised Dr. Hahn to apologize for misleading comments about the benefits of blood plasma for COVID-19.
"I did recommend that he correct the record," Mr. Pines said, adding that he wasn't told why his contract was severed. "If a federal official doesn't say something right, and chooses to clarify and say that the criticism is justified, that's refreshing," Mr. Pines said.
(With input from agencies)
